Since PDL-1 expression in cancer cells is known to inhibit the activity of PD-1+/CD8+ T cells [88], the combined effects of RGS5 and PDL-1 expression in pericytes may improve protection of tumor cells from T cell-mediated death. The gene discussed is RGS5; the disease is neoplasm.